• OPEN AN ACCOUNT
Indian Indices
Nifty
25,044.35 72.45
(0.29%)
Sensex
82,055.11 158.32
( 0.19%)
Bank Nifty
56,461.90 402.55
( 0.72%)
Nifty IT
38,417.95 3.85
( 0.01%)
Global Indices
Nasdaq
42,601.30 373.47
(0.88%)
Dow Jones
6,045.90 57.06
(0.95%)
Hang Seng
38,777.68 423.59
(1.10%)
Nikkei 225
8,758.04 -16.61
(-0.19%)
Forex
USD-INR
86.50 -0.18
(-0.20%)
EUR-INR
99.61 0.16
(0.17%)
GBP-INR
116.27 -0.12
(-0.11%)
JPY-INR
0.59 0.00
(-0.73%)

EQUITY - MARKET SCREENER

North Eastern Carrying Corporation Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
534615
INE553C01016
22.4079268
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NECCLTD
22.16
227.51
EPS(TTM)
Face Value()
Div & Yield %
1.07
10
0
 

Cohance Lifesciences' API Unit-IV clears USFDA inspection
May 26,2025

Cohance Lifesciences has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the inspection conducted at its API Unit-IV, located at Plot No. A-21, Road No. 10, IDA Nacharam, Uppal Mandal, Medchal-Malkajgiri, Telangana, India, from 03 March 2025 to 07 March 2025.

The inspection was classified as Voluntary Action Indicated (VAI) and indicates the formal closure of the inspection process by the USFDA.